JP2008540595A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540595A5
JP2008540595A5 JP2008511622A JP2008511622A JP2008540595A5 JP 2008540595 A5 JP2008540595 A5 JP 2008540595A5 JP 2008511622 A JP2008511622 A JP 2008511622A JP 2008511622 A JP2008511622 A JP 2008511622A JP 2008540595 A5 JP2008540595 A5 JP 2008540595A5
Authority
JP
Japan
Prior art keywords
thiazol
benzylidene
phenyl
group
piperazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008511622A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540595A (ja
JP5421589B2 (ja
Filing date
Publication date
Priority claimed from DE102005024012A external-priority patent/DE102005024012A1/de
Application filed filed Critical
Publication of JP2008540595A publication Critical patent/JP2008540595A/ja
Publication of JP2008540595A5 publication Critical patent/JP2008540595A5/ja
Application granted granted Critical
Publication of JP5421589B2 publication Critical patent/JP5421589B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008511622A 2005-05-20 2006-05-17 医薬への2,5−ジ置換されたチアゾール−4−オン誘導体の使用 Expired - Fee Related JP5421589B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005024012A DE102005024012A1 (de) 2005-05-20 2005-05-20 Verwendung von 2,5-disubstituierten Thiazol-4-on-Derivaten in Arzneimitteln
DE102005024012.7 2005-05-20
PCT/EP2006/004666 WO2006122777A2 (de) 2005-05-20 2006-05-17 Verwendung von 2,5-disubstituierten thiazol-4-on-derivaten in arzneimitteln

Publications (3)

Publication Number Publication Date
JP2008540595A JP2008540595A (ja) 2008-11-20
JP2008540595A5 true JP2008540595A5 (https=) 2013-01-10
JP5421589B2 JP5421589B2 (ja) 2014-02-19

Family

ID=36997851

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511622A Expired - Fee Related JP5421589B2 (ja) 2005-05-20 2006-05-17 医薬への2,5−ジ置換されたチアゾール−4−オン誘導体の使用

Country Status (8)

Country Link
US (1) US20090215758A1 (https=)
EP (1) EP1890695B1 (https=)
JP (1) JP5421589B2 (https=)
CA (1) CA2609002A1 (https=)
DE (1) DE102005024012A1 (https=)
ES (1) ES2402200T3 (https=)
PL (1) PL1890695T3 (https=)
WO (1) WO2006122777A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2934104B2 (ja) 1992-08-19 1999-08-16 ファナック株式会社 プレス間ワーク搬送装置
DE102007040336A1 (de) * 2007-08-27 2009-03-05 Johann Wolfgang Goethe-Universität Frankfurt am Main Neue Inhibitoren der 5-Lipoxygenase und deren Verwendungen
CL2009000294A1 (es) * 2008-02-08 2009-10-23 Shlorion Pharma Inc Compuestos derivados de heterociclos aril metilideno; composicion farmaceutica que los comprende; y uso en el tratamiento del dolor neuropatico e inflamacion.
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
WO2011092290A1 (en) 2010-02-01 2011-08-04 Novartis Ag Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
CN107249583B (zh) 2015-02-09 2021-05-07 国立大学法人冈山大学 乳酸脱氢酶抑制剂以及含有该抑制剂的抗癫痫剂
WO2021028518A1 (de) * 2019-08-15 2021-02-18 Bayer Aktiengesellschaft Verfahren zur herstellung von 2-(phenylimino)-3-alkyl-1,3-thiazolidin-4-onen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1604530A (https=) * 1967-06-06 1971-11-29
JP3871354B2 (ja) * 1994-07-29 2007-01-24 株式会社フジモト・コーポレーション 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体
JP3884096B2 (ja) * 1995-10-13 2007-02-21 株式会社フジモト・コーポレーション 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体
SE9701304D0 (sv) * 1997-04-09 1997-04-09 Astra Pharma Prod Compounds
HUP0104204A3 (en) * 1998-11-03 2002-06-28 Glaxo Group Ltd Pyrazolopyridine derivatives as cox-2 inhibitors, process for their preparation and pharmaceutical compositions thereof
WO2003057166A2 (en) * 2002-01-07 2003-07-17 Pharmacia Corporation Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
US7265138B2 (en) * 2003-02-10 2007-09-04 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US20090156644A1 (en) * 2005-07-21 2009-06-18 Jacob Westman Use of thiazole derivatives and analogues in the treatment of cancer

Similar Documents

Publication Publication Date Title
ES2295352T3 (es) Derivados de tiazol o de oxazol que son utiles en el tratamiento de enfermedades cardiovasculares y relacionadas con las mismas.
EP1244642B1 (en) Substituted oxazoles and thiazoles derivatives as hppar alpha activators
EP2010508A1 (en) Thiazol-guanidine derivatives useful as a (beta)- related pathologies
FR2872813A1 (fr) Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique
JP2008540595A5 (https=)
WO2002002542A1 (fr) Compose annulaire a cinq chainons
US20040171643A1 (en) Acylaminothiazole derivatives, their preparation and therapeutic use
JP2008526705A5 (https=)
EP1399430B1 (en) Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor
TW487707B (en) Improved process for the production of thiazolidinediones and new thiazolidinediones
AU2002317765A1 (en) Oxazol/ thiazol-derivatives activators of the hPPAR-alpha receptor
JP2008540595A (ja) 医薬への2,5−ジ置換されたチアゾール−4−オン誘導体の使用
KR100767895B1 (ko) 아자바이사이클로[3.1.0]헥산 화합물의 제조방법
EP1098895B1 (fr) Procede pour la preparation du sel potassique du lintitript
CA2530452A1 (en) Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators
JP2007015999A (ja) イミノチアゾール化合物の製造方法
JPH0125746B2 (https=)
HK1064367B (en) Oxazol/thiazol-derivatives activators of the hppar-alpha receptor
WO2000024740A1 (fr) Procede de preparation de derives de 4-(2-amino-1,3-thiazol-4-yl)benzenecarboximidamide
HU176455B (en) Process for producing thiasole derivatives
ZA200204241B (en) Substituted oxazoles and thiazoles derivatives as HPPAR Alpha Activators.